This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2025 — Pharmaceutical Compliance Congress
Delivered as a Hybrid Event
April 28-30, 2025The Ritz-Carlton, Tysons Corner | McLean, VA
Book Now
Menu
Book

Keren Tenenbaum
US General Counsel and Chief Compliance Officer at Ascendis Pharma
Speaker

Agenda Sessions

  • Risks from External Funding: Grants, Contributions, Corporate Contributions

    , 4:45pm
    View Session

At this event

Prev
Next
Natasha Trifun
Head of Compliance for R&D, Global Medical and Global Functions
Alexion, AstraZeneca Rare Disease

See Keren at PCC 2025 — Pharmaceutical Compliance Congress

Book Now